mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.06 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.06 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.06 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.07 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.07 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.07 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.07 |